methoxy-morpholinyl-doxorubicin has been researched along with Cancer of Colon in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, J; Cavalli, F; D'Incalci, M; de Jong, J; Domenigoni, L; Ghielmini, M; Naegele, H; Pacciarini, MA; Rossi, S; Sessa, C; Zucchetti, M | 1 |
1 trial(s) available for methoxy-morpholinyl-doxorubicin and Cancer of Colon
| Article | Year |
|---|---|
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243).
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Area Under Curve; Colonic Neoplasms; Doxorubicin; Female; Half-Life; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pancreatic Neoplasms | 1999 |